Compare CADL & GDEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CADL | GDEV |
|---|---|---|
| Founded | 1999 | 2009 |
| Country | United States | Cyprus |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 339.8M | 308.9M |
| IPO Year | 2021 | N/A |
| Metric | CADL | GDEV |
|---|---|---|
| Price | $6.01 | $15.97 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $19.43 | N/A |
| AVG Volume (30 Days) | ★ 979.3K | 6.1K |
| Earning Date | 11-13-2025 | 11-24-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 50.98 |
| EPS | N/A | ★ 3.08 |
| Revenue | N/A | ★ $412,018,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.89 |
| P/E Ratio | ★ N/A | $5.18 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.25 | $8.60 |
| 52 Week High | $13.68 | $42.20 |
| Indicator | CADL | GDEV |
|---|---|---|
| Relative Strength Index (RSI) | 60.31 | 41.74 |
| Support Level | $5.45 | $16.56 |
| Resistance Level | $6.14 | $17.91 |
| Average True Range (ATR) | 0.41 | 0.67 |
| MACD | 0.03 | 0.14 |
| Stochastic Oscillator | 43.40 | 5.23 |
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
GDEV Inc is a gaming and entertainment holding company that oversees a portfolio of studios focused on developing and publishing live-service games across a range of platforms and genres. Its portfolio includes studios specializing in mobile, browser, and PC games, as well as captivating IPs spanning various genres.